Hepatic glucose-6-phosphatase activity in non-insulin dependent diabetics. Effect of enzyme-inducing drugs.

The role of glucose-6-phosphatase (G6Pase) in postreceptional glucose handling in non-insulin dependent diabetics ( NIDDs ) was in investigated by comparing the enzyme values in diagnostic liver biopsy samples with fasting blood glucose (BG), immunoreactive insulin (IRI) and plasma antipyrine half-life (T/2). The NIDDs , treated with sulphonylureas, had elevated serum aminotransferase and alkaline phosphatase values associated with fatty liver with or without fibrosis. G6Pase activity was reduced in the NIDDs compared with subjects who had undergone gallstone surgery (p less than 0.001), insulin dependent diabetics (p less than 0.001), and age- and sex-matched non-diabetics (p less than 0.001). G6Pase was inversely related to BG and antipyrine T/2, but not to IRI or conventional liver function tests. Therapy with phenobarbital and medroxyprogesterone acetate, known inducers, increased G6Pase activity, shortened antipyrine T/2, reduced BG and did not alter IRI, in four NIDDs . Low liver G6Pase activity in NIDDs may hence be one factor underlying the impaired glycemic control.

[1]  J. Viikari,et al.  Fenfluramine Therapy in Non-insulin-dependent Diabetic Patients: Effects on Body Weight, Glucose Homeostasis, Serum Lipoproteins, and Antipyrine Metabolism , 1981, Diabetes Care.

[2]  G. Reaven,et al.  Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? , 1976, The American journal of medicine.

[3]  A. Lange,et al.  Modifications of hydrolytic and synthetic activities of liver microsomal glucose 6-phosphatase. , 1972, The Journal of biological chemistry.

[4]  R. DeFronzo,et al.  New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. , 1983, The American journal of medicine.

[5]  D. L. Schmucker,et al.  Effects of animal age and phenobarbital on rat liver glucose-6-phosphatase activity , 1980, Experimental Gerontology.

[6]  R. DeFronzo,et al.  The Pathogenesis of Non‐Insulin-Dependent Diabetes: AN UPDATE , 1982, Medicine.

[7]  A. Lange,et al.  Evidence for the participation of independent translocation for phosphate and glucose 6-phosphate in the microsomal glucose-6-phosphatase system. Interactions of the system with orthophosphate, inorganic pyrophosphate, and carbamyl phosphate. , 1980, The Journal of biological chemistry.

[8]  A. Rautio,et al.  Pericellular collagen in alcoholics with liver cirrhosis. , 1982, Research communications in chemical pathology and pharmacology.

[9]  J. Olefsky,et al.  Insulin resistance in noninsulin-dependent diabetes mellitus: impact of sulfonylurea agents in vivo and in vitro. , 1983, The American journal of medicine.

[10]  H. Ginsberg,et al.  Effect of Insulin Therapy on Insulin Resistance in Type II Diabetic Subjects: Evidence for Heterogeneity , 1981, Diabetes.

[11]  R. C. Nordlie Multifunctional glucose-6-phosphatase: cellular biology. , 1979, Life sciences.

[12]  B. Banks,et al.  Letter: SI units and nutrition. , 1975, Lancet.

[13]  H. Söling,et al.  Hepatic Enzyme Activities of Glycolysis and Gluconeogenesis in Diabetes of Man and Laboratory Animals* ** , 1970 .

[14]  R. B. Kerr,et al.  Insulin-sensitive and insulin-insensitive types of diabetes mellitus. , 1939 .

[15]  P. Felig,et al.  Influence of Oral Glucose Ingestion on Splanchnic Glucose and Gluconeogenic Substrate Metabolism in Man , 1975, Diabetes.

[16]  J. Halter,et al.  The Effect of Chronic Sulfonylurea Therapy on Hepatic Glucose Production in Non-insulin-dependent Diabetes , 1982, Diabetes.

[17]  J. Tulloch,et al.  Glucose-6-phosphatase activity in human diabetes. , 1957, Lancet.

[18]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[19]  P. Salmela,et al.  The Evaluation of the Drug-metabolizing Capacity in Patients with Diabetes Mellitus , 1980, Diabetes.

[20]  A. Beaudet,et al.  Type Ib glycogen storage disease is caused by a defect in the glucose-6-phosphate translocase of the microsomal glucose-6-phosphatase system. , 1980, The Journal of biological chemistry.

[21]  J. Olefsky The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes , 1976, Diabetes.

[22]  A. Conney Pharmacological implications of microsomal enzyme induction. , 1967, Pharmacological reviews.

[23]  Y. Israel,et al.  Hepatocyte demand and substrate supply as factors in the susceptibility to alcoholic liver injury: pathogenesis and prevention. , 1981, Clinics in gastroenterology.

[24]  R. Bergman Integrated control of hepatic glucose metabolism. , 1977, Federation proceedings.

[25]  L. Prescott,et al.  Rapid gas‐liquid chromatographic estimation of antipyrine in plasma , 1973, The Journal of pharmacy and pharmacology.

[26]  J. Stengård,et al.  Treatment of noninsulin‐dependent diabetes mellitus with enzyme inducers , 1983, Clinical pharmacology and therapeutics.